Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers (GHBCS-01)

This study has been completed.
Sponsor:
Information provided by:
AVIR Green Hills Biotechnology AG
ClinicalTrials.gov Identifier:
NCT00724997
First received: July 28, 2008
Last updated: December 7, 2009
Last verified: December 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
No publications provided by AVIR Green Hills Biotechnology AG

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):